Idera Pharmaceuticals Statistics
Share Statistics
Idera Pharmaceuticals has 0
shares outstanding. The number of shares has increased by 5.86%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | 5.86% |
| Shares Change (QoQ) | 0.32% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,242 |
| FTD / Avg. Volume | 9.53% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.05 and the forward
PE ratio is null.
Idera Pharmaceuticals's PEG ratio is
0.
| PE Ratio | -0.05 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.1 |
| P/FCF Ratio | -0.05 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Idera Pharmaceuticals has an Enterprise Value (EV) of -10.34M.
| EV / Sales | 0 |
| EV / EBITDA | 0.37 |
| EV / EBIT | 0.42 |
| EV / FCF | 0.42 |
Financial Position
The company has a current ratio of 0.83,
with a Debt / Equity ratio of 0.05.
| Current Ratio | 0.83 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | -144.48 |
Financial Efficiency
Return on Equity is -197.53% and Return on Invested Capital is -187.3%.
| Return on Equity | -197.53% |
| Return on Assets | -23.1% |
| Return on Invested Capital | -187.3% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,796,923.08 |
| Employee Count | 13 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6.32M |
| Effective Tax Rate | 21.29% |
Stock Price Statistics
The stock price has increased by -1.18% in the
last 52 weeks. The beta is 0, so Idera Pharmaceuticals's
price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -1.18% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 0.44 |
| Relative Strength Index (RSI) | 49.78 |
| Average Volume (20 Days) | 34,017 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.47M |
| Net Income | -23.36M |
| EBITDA | -27.82M |
| EBIT | -29.47M |
| Earnings Per Share (EPS) | -7.18 |
Full Income StatementBalance Sheet
The company has 12.04M in cash and 560K in
debt, giving a net cash position of 11.48M.
| Cash & Cash Equivalents | 12.04M |
| Total Debt | 560K |
| Net Cash | 11.48M |
| Retained Earnings | -758.82M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -24.5M
and capital expenditures 0, giving a free cash flow of -24.5M.
| Operating Cash Flow | -24.5M |
| Capital Expenditures | n/a |
| Free Cash Flow | -24.5M |
| FCF Per Share | -7.52 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
